Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06177522
Status:
RECRUITING
Last Update Posted:
2023-12-20
First Post:
2023-12-11
Brief Title:
Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
Sponsor:
Jinling Hospital China
Organization:
Jinling Hospital China
Organization Data
Organization:
Jinling Hospital China
Class:
OTHER
Study ID:
DZQH-KYLL-23-26
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jinling Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
Sizhen Wang
Responsible Party Title:
associate chief physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Jinling Hospital China
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jiangsu Hengrui Pharmaceutical Co Ltd | INDUSTRY |